Document:

</title>
<!-- Licensed to: EDGARfilings-->
<!-- Document Created using EDGARizer HTML 3.0.4.0 -->
<!-- Copyright 2006 EDGARfilings, Ltd., an IEC company.-->
<!-- All rights reserved EDGARfilings.com -->
</head>

<body>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="33%" valign="top"><p>&#160;</p>
</td>
<td width="33%" style="border-top: 0.0266667in solid; border-bottom: 0.0266667in solid" align="center" valign="top"><p>EXHIBIT 10.1</p>
</td>
<td width="34%" valign="top"><p>&#160;</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>&#160;</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>December 23, 2005</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>L. A. Newlan, Jr., 2652, F.M. 407, Suite 230, Bartonville, Texas 76226</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>Re: Amendment to Consulting Agreement</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>Dear Lee:</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>Due to the recent adoption of FAS-123R by the Financial Accounting Standards Board that
requires companies to apply a fair-value-based measurement method in accounting for share-based payment transactions with employees and certain consultants, we must establish a floor
price for the options granted to you under your consulting agreement.  We propose that a floor
exercise price of $.02 share be established.  In addition, we propose that the term of your
agreement be extended for an additional six months.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>Should the foregoing floor exercise price and extension be acceptable to you, please sign in the
space below and fax a copy to us.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>Thank you for your consideration.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>Sincerely,</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>/s/ DAVID LOFLIN</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>David Loflin</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>President</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>&#160;</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>AGREED AND ACCEPTED:</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>/s/ L.A. NEWLAN, JR.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>L.A. Newlan, Jr.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>&#160;</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" align="center" valign="top"><p>CONSULTING AGREEMENT</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>This Consulting Agreement is made as of the 11th day of August, 2005, by and between L.A.
Newlan, Jr., a resident of the State of Texas ("Consultant"), and Diamond I, Inc, a Delaware
corporation (the "Company").</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>WHEREAS, Consultant possesses experience in the field of international business
development; and</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>WHEREAS, the Company is a publicly-held company and files periodic reports pursuant to
the requirements of the Securities Exchange Act of 1934, with its common stock quoted on the
OTC Bulletin Board under the symbol &#8220;DMOI&#8221;; and</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>WHEREAS, the Company desires to hire Consultant and Consultant is willing to accept the
Company as a client.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" style="height: 0.3325in" valign="top"><p>NOW THEREFORE, in consideration of the mutual covenants herein contained, it is agreed:</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>1.</p>
</td>
<td width="92%" valign="top"><p>The Company hereby engages Consultant, on a non-exclusive basis, to render
consulting services with respect to international business development.  Consultant
hereby accepts such engagement and agrees to render such consulting services as are
listed on Exhibit &#8220;A&#8221; attached hereto and incorporated herein by this reference,
throughout the term of this Agreement.  Consultant agrees that he shall be responsible
for ordinary, day-to-day expenses incurred in its performance hereunder.  The
Company shall however be responsible for all postage and printing expenses, which
shall be reimbursable on a monthly basis, upon receipt by the Company of an invoice
from Consultant in respect thereof. All other expenses, such as traveling and
accommodation, shall be negotiated on a case-by-case basis.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>&#160;</p>
</td>
<td width="92%" valign="top"><p>It is further agreed that Consultant shall have no authority to bind the Company to any
contract or obligation or to transact any business in the Company&#8217;s name or on behalf
of the Company, in any manner.  The parties intend that Consultant shall perform its
services required hereunder as an independent contractor.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>2.</p>
</td>
<td width="92%" valign="top"><p>The initial term of this Agreement shall commence upon the mutual execution of this
Agreement and shall continue until August 10, 2006.  This Agreement may be
terminated by either party, without cause, after 90 days from the date of mutual
execution hereof, on 30 days&#8217; written notice.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>3.</p>
</td>
<td width="92%" valign="top"><p>In consideration of the services to be performed by Consultant, the Company agrees to
pay to Consultant the compensation set forth on Exhibit &#8220;B&#8221; attached hereto and
incorporated herein by this reference.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>4.</p>
</td>
<td width="92%" valign="top"><p>The Company represents and warrants to Consultant that:</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="15%" align="right" valign="top"><p>A.</p>
</td>
<td width="85%" valign="top"><p>The Company will cooperate fully and timely with Consultant to enable
Consultant to perform its obligations hereunder.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="15%" align="right" valign="top"><p>B.</p>
</td>
<td width="85%" valign="top"><p>The execution and performance of this Agreement by the Company has been
duly authorized by the Board of Directors of the Company.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="15%" align="right" valign="top"><p>C.</p>
</td>
<td width="85%" valign="top"><p>The performance by the Company of this Agreement will not violate any
applicable court decree, law or regulation, nor will it violate any provisions of
the organizational documents of the Company or any contractual obligation by
which the Company may be bound.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>5.</p>
</td>
<td width="92%" valign="top"><p>Until such time as the same may become publicly known, the parties agree that any
information provided to either of them by the other of a confidential nature will not be
revealed or disclosed to any person or entity, except in the performance of this
Agreement, and upon completion of Consultant's services and upon the written request
of the Company, any original documentation provided by the Company will be
returned to it.  Consultant, including each of its affiliates, will not directly or indirectly
buy or sell the securities of the Company at any time when it or they are privy to non-public information.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>&#160;</p>
</td>
<td width="92%" valign="top"><p>Consultant agrees that he will not disseminate any printed matter relating to the
Company without prior written approval of the Company.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>&#160;</p>
</td>
<td width="92%" valign="top"><p>Consultant agrees that he will comply with all applicable securities laws, in performing
on behalf of the Company hereunder.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>6.</p>
</td>
<td width="92%" valign="top"><p>All notices hereunder shall be in writing and addressed to the party at the address
herein set forth, or at such other address as to which notice pursuant to this section may
be given, and shall be given by personal delivery, by certified mail (return receipt
requested), Express Mail or by national or international overnight courier.  Notices will
be deemed given upon the earlier of actual receipt of three (3) business days after being
mailed or delivered to such courier service.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>&#160;</p>
</td>
<td width="92%" valign="top"><p>Notices shall be addressed to Consultant at:</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="16%" valign="top"><p>&#160;</p>
</td>
<td width="84%" valign="top"><p>L. A. Newlan, Jr., 2652 F.M. 407, Suite 230, Bartonville, Texas 76226</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>&#160;</p>
</td>
<td width="92%" valign="top"><p>and to the Company at:</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>&#160;</p>
</td>
<td width="92%" valign="top"><p>Diamond I, Inc., Attention: David Loflin, 5555 Hilton Avenue, Suite 207, Baton
Rouge, Louisiana 70808</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>7.</p>
</td>
<td width="92%" valign="top"><p>Miscellaneous.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="15%" align="right" valign="top"><p>A.</p>
</td>
<td width="85%" valign="top"><p>In the event of a dispute between the parties arising out of this Agreement, both
Consultant and the Company agree to submit such dispute to arbitration before
the American Arbitration Association (the "Association") at its Dallas, Texas,
offices, in accordance with the then-current rules of the Association; the award
given by the arbitrators shall be binding and a judgment can be obtained on any
such award in any court of competent jurisdiction.  It is expressly agreed that
the arbitrators, as part of their award, can award attorneys fees to the prevailing
party.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="15%" align="right" valign="top"><p>B.</p>
</td>
<td width="85%" valign="top"><p>This Agreement is not assignable in whole or in any part, and shall be binding
upon the parties, their heirs, representatives, successors or assigns.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="15%" align="right" valign="top"><p>C.</p>
</td>
<td width="85%" valign="top"><p>This Agreement may be executed in multiple counterparts which shall be
deemed an original.  It shall not be necessary that each party execute each
counterpart, or that any one counterpart be executed by more than one party, if
each party executes at least one counterpart.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="15%" align="right" valign="top"><p>D.</p>
</td>
<td width="85%" valign="top"><p>This Agreement shall be governed by, and construed in accordance with, the
laws of the State of Delaware.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="38%" valign="top"><p>&#160;</p>
</td>
<td width="62%" valign="top"><p>DIAMOND I, INC.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="38%" valign="top"><p>&#160;</p>
</td>
<td width="62%" valign="top"><p>By: /s/ DAVID LOFLIN</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="38%" valign="top"><p>&#160;</p>
</td>
<td width="62%" valign="top"><p>David Loflin, President</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>&#160;</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="38%" valign="top"><p>&#160;</p>
</td>
<td width="62%" valign="top"><p>/s/ L.A. NEWLAN, JR.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="38%" valign="top"><p>&#160;</p>
</td>
<td width="62%" valign="top"><p>L. A. Newlan, Jr.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>&#160;</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>Exhibit &#8220;A&#8221;, Consulting Agreement, L. A. Newlan, Jr.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>SERVICES TO BE PERFORMED BY CONSULTANT ON BEHALF OF THE COMPANY</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>The consulting services to be provided by Consultant under the Consulting Agreement to
which this Exhibit &#8220;A&#8221; is attached include, but shall not be limited to:</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="5%" valign="top"><p>-</p>
</td>
<td width="95%" valign="top"><p>Advise the Company and provide assistance in the area of business development and
strategies for achieving Company growth in foreign (non-U.S.) Markets.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="5%" valign="top"><p>-</p>
</td>
<td width="95%" valign="top"><p>Identify potential foreign (non-U.S.) end-users of the Company&#8217;s communications
products and development of business systems and strategies for delivering such products
thereto.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="5%" valign="top"><p>-</p>
</td>
<td width="95%" valign="top"><p>Assist the Company in identifying and contracting with required professionals, as needed.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>Consultant shall perform these services with the understanding that the above-referenced
services will be performed principally in the United States.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>It is understood that there may be times when the Company does not utilize the services or
advice of Consultant.  Any such failure of the Company to use, or seek in writing, Consultant&#8217;s
advice and/or services and/or assistance, as set forth herein, shall not be deemed to be non-performance hereunder by Consultant.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>Exhibit &#8220;B&#8221;, Consulting Agreement, L. A. Newlan, Jr.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>COMPENSATION TO BE PAID BY THE COMPANY TO CONSULTANT</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>As full payment for Consultant&#8217;s services under the Consulting Agreement (the &#8220;Agreement&#8221;)
to which this Exhibit &#8220;B&#8221; relates, Consultant shall receive options to purchase shares of the
Company&#8217;s common stock, as follows:</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="100%" valign="top"><p>Consultant represents and warrants that he has investigated the Company, its financial
condition, business and prospects, and has had the opportunity to ask questions of, and to
receive answers from, the Company with respect thereto.  Consultant acknowledges that it is
aware that the Company currently lacks adequate capital to pursue its full plan of business.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>1.</p>
</td>
<td width="92%" valign="top"><p>Number of Shares; Exercise Price.  Pursuant to action taken by the Company&#8217;s board
of directors, the Company hereby grants to Consultant, in consideration of consulting
services to be performed for the benefit of the Company pursuant to the Agreement, an
option ("Option") to purchase the number of shares of Company common stock
("Option Shares") set forth below, at the exercise price set forth below:</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="15%" valign="top"><p>&#160;</p>
</td>
<td width="85%" valign="top"><p>Number of Shares: a number of shares having a value, as determined below, of
up to $300,000.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="15%" valign="top"><p>&#160;</p>
</td>
<td width="85%" valign="top"><p>Exercise Price: 85.00% of the closing bid price, as reported by the OTC
Bulletin Board, on date of exercise.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>2.</p>
</td>
<td width="92%" valign="top"><p>Method and Time of Exercise. The Option may be exercised, on a monthly basis,
beginning in August 2005, to purchase a number of shares not exceed $25,000 in value
(as determined above) per month, by written notice delivered to the Company stating
the number of Option Shares with respect to which the Option is then being exercised,
together with a check, payable to the Company, or a wire transfer to the Company in
the amount equal to the Exercise Price, multiplied by the number of Option Shares then
being issued pursuant to the written notice of exercise.  Only whole shares shall be
issued upon exercise of the Option.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>3.</p>
</td>
<td width="92%" valign="top"><p>Term. The Option shall expire concurrently with the term of the Agreement.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>4.</p>
</td>
<td width="92%" valign="top"><p>Tax Withholding. As a condition to exercise of the Option, the Company may require
Consultant to pay to the Company all applicable federal, state and local taxes which the
Company is required to withhold with respect to the exercise of the Option.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>5.</p>
</td>
<td width="92%" valign="top"><p>Transferability. The Option and this Agreement may not be assigned or transferred by
Consultant, without the prior written consent of the Company.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>6.</p>
</td>
<td width="92%" valign="top"><p>Consultant Not a Shareholder.  Consultant shall have no right as a shareholder with
respect to the Option Shares issued from time to time upon exercise of the Option until
the earlier of:  (A) the date of issuance of a stock certificate or stock certificates to
Consultant applicable to the Option Shares then issuable to Consultant upon exercise
of the Option; and (B) the date on which Consultant is recorded as owner of such
Option Shares on the Company's stock ledger by the Company's registrar and transfer
agent.  Except as set forth in paragraph 10 of this Agreement, no adjustment shall be
made for dividends or other rights for which the record date is prior to the earlier of the
event described in clauses (A) and (B) of this paragraph.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>7.</p>
</td>
<td width="92%" valign="top"><p>Restrictions on Transfer. Consultant represents and agrees that, upon Consultant&#8217;s
exercise of the Option, unless there is in effect at that time under the Securities Act of
1933, as amended, a registration statement relating to the Option Shares, Consultant
shall acquire the Option Shares for the purpose of investment and not with a view to
their resale or further distribution, and that, upon such exercise hereof, Consultant will
furnish to the Company a written statement to such effect, satisfactory to the Company
in form and substance.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>8.</p>
</td>
<td width="92%" valign="top"><p>Shares Qualified for Listing.  The Company represents that its common stock is
qualified for trading or quotation on a nationally recognized securities exchange or
stock quotation system, including, without limitation, NASDAQ&#8217;s OCT Bulletin
Board.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>9.</p>
</td>
<td width="92%" valign="top"><p>Status of Shares Underlying the Option Shares. All Option Shares issuable to
Consultant shall be issued pursuant an effective registration statement under the
Securities Act of 1933, as amended, including a registration statement on Form S-8.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>10.</p>
</td>
<td width="92%" valign="top"><p>Adjustments.  If there is any change in the capitalization of the Company after the date
of the Agreement affecting in any manner the number or kind of outstanding shares of
common stock of the Company, whether by stock dividend, stock splits,
reclassification or recapitalization of such stock, or because the Company has merged
or consolidated with one or more other corporations, then the number and kind of
shares then subject to the Option and the exercise price to be paid for the Option Shares
shall be appropriately adjusted by the board of directors of the Company; provided,
however, that in no event shall any such adjustment result in the Company being
required to sell or issue any fractional shares. Any such adjustment shall be made
without change in the aggregate exercise price applicable to the unexercised portion of
the Option, but with an appropriate adjustment to the exercise price of each Option
Share or other unit of security then covered by the Option and the Agreement.</p>
</td>
</tr>
</table>
<table width="100%" cellpadding="6" cellspacing="0">
<tr>
<td width="8%" valign="top"><p>11.</p>
</td>
<td width="92%" valign="top"><p>Cessation of Corporate Existence. Notwithstanding any other provision of this
Agreement, in the event of the reorganization, merger or consolidation of the Company
with one or more corporations as a result of which the Company is not the surviving
corporation, or the sale of substantially all of the assets of the Company or of more
than fifty percent (50%) of the then outstanding stock of the Company to another
corporation or other entity in a single transaction, the Option granted hereunder shall
terminate; provided, however, that not later than five (5) days before the effective date
of such merger or consolidation or sale of assets in which the Company is not the
surviving corporation, the surviving corporation may, but shall not be so obligated to,
tender to Consultant an option to purchase a number of shares of capital stock of the
surviving corporation equal to the number of Option Shares then issuable upon
exercise of the Option, and such new option or options for shares of the surviving
corporation shall contain such terms, conditions and provisions as shall be required
substantially to preserve the rights and benefits of the Option and this Agreement.</p>
</td>
</tr>
</table>
</body>

</html>LICENSING / PURCHASE AGREEMENT

                          Dated as of January 31, 2005

                                      Among

                             THE CHELSEA COLLECTION

                                      and

                            GATEWAY DISTRIBUTORS LTD

                                        1
<PAGE>
    THIS AGREEMENT ("Agreement"), dated as of January 27 2005 , is by and among
    Gateway Distributors Ltd, a Nevada Corporation ("Gateway") and The Chelsea
                                                    ----------
                Collection Inc, a Nevada corporation ("Chelsea")

                                    RECITALS

     A.  "Chelsea"  has the right to purchase all of the rights, trademarks, and
         ---------
formulas  of  all  the GH-3 products exclusively upon satisfactory completion of
all  obligations  owed to Francois Vautour in agreement dated November 25, 2003.

     B.  The  parties  hereto  wish to provide for the terms and conditions upon
which  the  "Gateway"  will  acquire the licensing rights to the GH-3. This will
allow  "Gateway"  to  solicit  investors  and  licensees.

     C.  The  parties  hereto  wish to make certain representations, warranties,
covenants  and  agreements  in  connection with the licensing agreement, also to
prescribe  various  conditions  to  such  transaction.

                                    AGREEMENT

     Accordingly, and in consideration of the representations, warranties,
covenants, agreements and conditions herein contained, the parties hereto agree
as follows:

                                    ARTICLE 1
                                    ---------

                               LICENSING AGREEMENT
                               -------------------
1.  Licensing  .  Upon  satisfaction  of  all  conditions  to the obligations of
   ----------
the  parties  contained herein to Francois Vautour as set forth in the Agreement
dated  Nov.  25,  2003, (other than such conditions as shall have been waived in
accordance  with the terms hereof), "Chelsea" shall give the licensing rights to
Gateway  Distributors  Ltd for the G-H-3 Therapy. "Gateway will promote and seek
investors  and  licensees  for  the  G-H-3  for  "Chelsea."
     a.  Licensing rights of the GH-3 by Chelsea included shall be conveyed free
and  clear of any mortgage, pledge, lien, security interest, encumbrance, claim,
easement,  right-of-way,  tenancy, covenant, encroachment, restriction or change
of  any  kind  or  nature. (Whether or not of record) This will only be the case
once  the  obligations  to  Francois  Vautour  set  forth in the Agreement dated
November  25,  2003  have  been  totally  satisfied.

2.     Purchase Price.  "Chelsea" shall compensate "Gateway" 15% of all revenues
       ---------------
generated related to the G-H-3 Therapy and products as a finders fee.
     a. Inventory Stream. Inventory will be the responsibility of the Licensee
        -----------------
     and/or  clinic. The products will be purchased direct from the manufacturer
     designated  by  Francois  Vautour.  No  changes in production, formulation,
     marketing material, manufacturers etc. can only be made by written approval
     of  Francois  Vautour.
     b.  Revenue  Payment.  "Chelsea"  will pay 15% of all revenues generated by
         -----------------  ---------

                                        2
<PAGE>
     "Gateway"  related to the GH 3 Therapy and its products minus cost of goods
     according  to  GAP  rules.

     c.  Francois  Vautour will receive ten million shares of Preferred Class B
     stock  to  be  issued  upon signing of this agreement. Certificates will be
     issued  and  forwarded  to Francois Vautour as soon as possible, however no
     later  than  February  5,  2005.

     d.  This  agreement  will  not  in  any  way  jeopardize  any  terms of the
     Agreement  dated November 25, 2003 between Francois Vautour and The Chelsea
     Collection.

     e.  In  the  event Chelsea sells its rights to the GH 3 Therapy or the GH-3
PLUS products, to any other entity, Francois Vautour, Rick Bailey and Flo Ternes
shall  each  receive  one-third  of the total proceeds of said sale, whether the
proceeds  are  received  in cash or in the stock of an acquiring Chelsea. In the
event  Gateway  sells  substantially  all of the stock in, or assets of, Gateway
Corporation,  Chelsea must approve of the Buyer of this agreement and Buyer must
agree  to  all  conditions within this agreement and continue the 15% payment on
sale  of  Jeunesse  products  to  The  Chelsea  Collection.

     f.  This contract is unassignable without the debt owed to Francois Vautour
     being  satisfied  without  the  written  approval  of  Francois  Vautour.

     g.  All  third  party  licensing  via  Gateway  must go through "Chelsea".

3.     Corporate  Organization.  The  "Gateway"  is validly existing and in good
       ------------------------       ---------
standing  under  the  laws  of  the  state  of  Nevada.

4.  Authorization. The "Chelsea" has full corporate power and authority to enter
    --------------     ---------
into  this  Agreement and the "Chelsea" Delivered Documents and to carry out the
transactions  contemplated  herein  and  therein.

6.  Intellectual  Property Rights. The "Chelsea" has the right to purchase under
    ------------------------------     ---------
the  Nov.  25,  2003 Agreement, the industrial and intellectual property rights,
including  without  limitation  the patents, patent applications, patent rights,
trademarks,  trademark  applications,  trade  names, service marks, service mark
applications,  copyrights,  computer  programs  and  other  computer  software,
inventions,  know-how,  trade  secrets,  technology,  proprietary  processes and
formulae (collectively, "Intellectual Property Rights"). To the knowledge of the
                        --------------------------------
"Chelsea"  the use of all Intellectual Property Rights necessary or required for
the  conduct  of  the  businesses of the "Chelsea" as presently conducted and as
proposed  to  be conducted does not and, to the knowledge of the "Chelsea", will
                                                                 ----------
not  infringe  or  violate  or  allegedly  infringe  or violate the intellectual
property  rights  of any person or entity. The "Chelsea" does not own or use any
                                               ---------
Intellectual  Property  Rights pursuant to any written license agreement, except
for  the  Nov. 25, 2003 Agreement with Francois Vautour, and has not granted any
person  or

                                        3
<PAGE>
entity  any  rights,  pursuant to written license agreement or otherwise, to use
the  Intellectual  Property  Rights.

8.  This  Agreement  is  a  licensing  agreement  and excludes any rights to the
purchase  of  GH 3 Therapy and affiliated products. Purchase of the GH 3 Therapy
must  be  negotiated  separately  with  the  "Chelsea". This does not effect the
licensing agreement with The Chelsea Collection and Gateway as it relates to the
Jeunesse  skin  care.

9.  Confidentiality.  Each  of  the  parties hereto agrees that it will not use,
    ----------------
or  permit the use of, any of the information relating to any other party hereto
furnished  to  it  in  connection  with  the  transactions  contemplated  herein
("Information")  in a manner or for a purpose detrimental to such other party or
        -------
otherwise  than  in  connection  with  the  transaction,  and that they will not
disclose,  divulge,  provide  or  make  accessible,  or permit the Disclosure of
(collectively,  "Disclose"  or  "Disclosure"  as  the  case  may be), any of the
                ----------      ------------
Information  to  any  person  or entity, other than their responsible directors,
officers,  employees,  investment  advisors,  accountants,  counsel  and  other
authorized  representatives and agents, except as may be required by judicial or
administrative  process  or,  in the opinion of such party's regular counsel, by
other  requirements  of  Law; provided, however, that prior to any Disclosure of
                              --------- --------
any Information permitted hereunder, the disclosing party shall first obtain the
recipients'  undertaking  to  comply with the provisions of this subsection with
respect  to  such  information.  The term "Information" as used herein shall not
                                          -------------
include  any  information  relating  to  a party which the party disclosing such
information  can  show:  (i) to have been in its possession prior to its receipt
from another party hereto; (ii) to be now or to later become generally available
to  the  public  through  no  fault  of the disclosing party; (iii) to have been
available to the public at the time of its receipt by the disclosing party; (iv)
to  have  been  received  separately  by the disclosing party in an unrestricted
manner  from a person entitled to disclose such information; or (v) to have been
developed  independently  by  the  disclosing  party  without  regard  to  any
information received in connection with this transaction. Each party hereto also
agrees to promptly return to the party from who originally received all original
and  duplicate  copies  of  written  materials containing Information should the
transactions  contemplated  herein  not occur. A party hereto shall be deemed to
have  satisfied  its  obligations  to  hold  the  Information confidential if it
exercises the same care as it takes with respect to its own similar information.

10.  Governing  Law.  This  Agreement  and the legal relations among the parties
     --------------
hereto  shall  be  governed  by  and  construed  in accordance with the internal
substantive  laws of the State of Nevada (without regard to the laws of conflict
that  might  otherwise  apply)  as  to all matters, including without limitation
matters  of  validity,  construction,  effect,  performance  and  remedies.

11.  Arbitration.  Any  controversy  or claim arising out of or relating to this
     ------------
Agreement,  or  the  making,  performance  or  interpretation thereof, including
without  limitation  alleged  fraudulent inducement thereof, shall be settled by
binding  arbitration  in  Las  Vegas,  Nevada by a panel of three arbitrators in
accordance  with  the  Commercial  Arbitration

                                        4
<PAGE>
Rules  of  the  American  Arbitration Association. Judgment upon any arbitration
award  may  be  entered in any court having jurisdiction thereof and the parties
consent  to  the  jurisdiction  of  the  courts of the State, of Nevada for this
purpose.

12.  Default.  If  Gateway fails to issue the stock to Francois Vautour, he will
     --------
exercise  the  right  as  President  of  "Chelsea"  to  withdraw  the  licensing
agreement.  Francois  Vautour can cancel this agreement in writing with a thirty
day  notice.

13.  If  there  is a breach of the contract between The Chelsea Collection, Inc.
and  Gateway  Distributors, Ltd that results in litigation, the prevailing party
shall  be entitled to attorney's fees and costs in the arbitration process. This
will  also  include  Francois  Vautour,  Rick  Bailey,  and  Florian  Ternes  as
individuals.

14.  The  Chelsea  Collection  has  the  right  to  inspect  and  photo copy all
accounting  functions  to  verify  the  sales  of  the  GH  3  Therapy.
IN  WITNESS  WHEREOF,  the  parties hereto have caused this Agreement to be duly
executed  as  of  the  day  and  year  first  above written. This agreement will
supercede  all  previous  agreements  both  written  and  verbal.

"GATEWAY"                                       "CHELSEA"

GATEWAY DISTRIBUTORS LTD                THE CHELSEA COLLECTION, INC.

By                                       By
  ----------------------------             -----------------------------

     Rick Bailey                         Francois Vautour
     President / CEO                     President / CEO

                                        5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]